Lumexa Imaging Holdings, Inc. (LMRI)

Market Cap	1.12B
Revenue (ttm)	1.04B +10.0%
Net Income	-27.73M
EPS	-0.33
Shares Out	96.07M
PE Ratio	n/a
Forward PE	14.39
Dividend	n/a
Ex-Dividend Date	n/a

Volume	260,072
Open	11.44
Previous Close	11.51
Day's Range	11.40 - 11.74
52-Week Range	6.45 - 19.45
Beta	n/a
Analysts	Strong Buy
Price Target	17.57 (+50.56%)
Earnings Date	Aug 12, 2026

About LMRI

Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Dec 11, 2025
• Employees: 4,335
• Stock Exchange: NASDAQ
• Ticker Symbol: LMRI
• Website: https://www.lumexaimaging.com

Financial Performance

In 2025, Lumexa Imaging Holdings's revenue was $1.02 billion, an increase of 7.82% compared to the previous year's $948.87 million. Losses were -$47.10 million, -49.94% less than in 2024.

Analyst Summary

According to 8 analysts, the average rating for LMRI stock is "Strong Buy." The 12-month stock price target is $17.57, which is an increase of 50.56% from the latest price.

Price Target

$17.57

(50.56% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Aug 31, 2026

Data Sources Report a data error